Teva Pharmaceutical Industries Limited (
) will begin trading ex-dividend on November 18, 2013. A cash
dividend payment of $0.326 per share is scheduled to be paid on
December 02, 2013. Shareholders who purchased TEVA stock prior to
the ex-dividend date are eligible for the cash dividend payment.
This represents an 1.24% increase over the prior quarter. At the
current stock price of $38.35, the dividend yield is 3.4%.
The previous trading day's last sale of TEVA was $38.35,
representing a -10.46% decrease from the 52 week high of $42.83 and
a 5.76% increase over the 52 week low of $36.26.
TEVA is a part of the Health Care sector, which includes
companies such as Johnson & Johnson (
) and Pfizer, Inc. (
). TEVA's current earnings per share, an indicator of a company's
profitability, is $1.42. Zacks Investment Research reports TEVA's
forecasted earnings growth in 2013 as -7.1%, compared to an
industry average of -3.3%.
For more information on the declaration, record and payment
dates, visit the
has the full list of stocks that have an ex-dividend today.
Interested in gaining exposure to TEVA through an Exchange
Traded Fund [ETF]?
The following ETF(s) have TEVA as a top-10 holding:
- iShares MSCI Israel Capped Investable Market Index Fund (
The top-performing ETF of this group is EIS with an increase of
7.9% over the last 100 days. It also has the highest percent
weighting of TEVA at 21.84%.